Ligand efficiency: a useful metric for lead selection

Sneader, 1996

Hann, 2001, Molecular complexity and its impact on the probability of finding leads for drug discovery, J. Chem. Inf. Comput. Sci., 41, 856, 10.1021/ci000403i

Teague, 1999, The design of leadlike combinatorial libraries, Angew Chem. Int. Ed. Engl., 24, 3743, 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U

Oprea, 2001, Is there a difference between leads and drugs?, J. Chem. Inf. Comput. Sci., 41, 1308, 10.1021/ci010366a

Lipinski, 2000, Drug-like properties and the causes of poor solubility and poor permeability, J. Pharmacol. Toxicol. Methods, 44, 235, 10.1016/S1056-8719(00)00107-6

Lipinski, 1997, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Del. Revs., 23, 3, 10.1016/S0169-409X(96)00423-1

Wenlock, 2003, A comparison of physiochemical property profiles of development and marketed oral drugs, J. Med. Chem., 46, 1250, 10.1021/jm021053p

Blake, 2003, Examination of the computed molecular properties of compounds selected for clinical development, BioTechniques, 34, S16, 10.2144/blakejun03

Lahana, 1999, How many leads from HTS?, Drug Disc. Today, 4, 447, 10.1016/S1359-6446(99)01393-8

Andrews, 1984, Functional group contributions to drug-receptor interactions, J. Med. Chem., 27, 1648, 10.1021/jm00378a021

Kuntz, 1999, The maximal affinity of ligands, Proc. Natl. Acad. Sci. U. S. A., 96, 9997, 10.1073/pnas.96.18.9997